Asymmetric synthesis of an N-acylpyrrolidine for inhibition of HCV polymerase

被引:42
作者
Agbodjan, Armel A. [2 ]
Cooley, Bob E. [2 ]
Copley, Royston C. B. [3 ]
Corfield, John A. [1 ]
Flanagan, Roy C. [2 ]
Glover, Bobby N. [2 ]
Guidetti, Rossella [1 ]
Haigh, David [1 ]
Howes, Peter D. [1 ]
Jackson, Mary M. [2 ]
Matsuoka, Richard T. [2 ]
Medhurst, Katrina J.
Millar, Alan [2 ]
Sharp, Matthew J. [2 ]
Slater, Martin J. [1 ]
Toczko, Jennifer F. [2 ]
Xie, Shiping [2 ]
机构
[1] GlaxoSmithKline, GSK Med Res Ctr, Stevenage SG1 2NY, Herts, England
[2] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Harlow CM19 5AW, Essex, England
关键词
D O I
10.1021/jo800062c
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A practical asymmetric synthesis of a highly substituted N-acylpyrrolidine on multi-kilogram scale is described. The key step in the construction of the three stereocenters is a [3+2] cycloaddition of methyl acrylate and an imino ester prepared from L-leucine t-butyl ester hydrochloride and 2-thiazolecarboxaldehyde. The cycloaddition features novel asymmetric catalysis via a complex of silver acetate and a cinchona alkaloid, particularly hydroquinine, with complete diastereomeric control and up to 87% enantiomeric control. The alkaloid serves as a ligand as well as a base for the formation of the azomethine ylide or 1,3-dipole. Experiments have shown that the hydroxyl group of hydroquinine is a critical element for the enantioselectivities observed. The cycloaddition methodology is also applicable to methylvinyl ketone, providing access to either alpha- or beta-epimers of 4-acetylpyrrolidine depending on the reaction conditions utilized. The synthesis also highlights an efficient N-acylation, selective O- versus N-methylation, and a unique ester reduction with NaBH4-MeOH catalyzed by NaB(OAc)(3)H that not only achieves excellent chemoselectivity but also avoids formation of the undesired but thermodynamically favored epimer. The highly functionalized target is synthesized in seven linear steps from L-leucine t-butyl ester hydrochloride with all three isolated intermediates being highly crystalline.
引用
收藏
页码:3094 / 3102
页数:9
相关论文
共 22 条
[1]   A convenient procedure for the catalytic asymmetric 1,3-dipolar cycloaddition of azomethine ylides and alkenes [J].
Alemparte, C ;
Blay, G ;
Jorgensen, KA .
ORGANIC LETTERS, 2005, 7 (21) :4569-4572
[2]   Epidemiology of hepatitis C [J].
Alter, MJ .
HEPATOLOGY, 1997, 26 (03) :S62-S65
[3]  
Beaulieu Pierre L, 2004, Curr Opin Investig Drugs, V5, P838
[4]   Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture [J].
Burton, G ;
Ku, TW ;
Carr, TJ ;
Kiesow, T ;
Sarisky, RT ;
Lin-Goerke, J ;
Baker, A ;
Earnshaw, DL ;
Hofmann, GA ;
Keenan, RM ;
Dhanak, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) :1553-1556
[5]   Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activity [J].
Burton, George ;
Ku, Thomas W. ;
Carr, Thomas J. ;
Kiesow, Terry ;
Sarisky, Robert T. ;
Lin-Goerke, Juill ;
Hofmann, Glenn A. ;
Slater, Martin J. ;
Haigh, David ;
Dhanak, Dashyant ;
Johnson, Victor K. ;
Parry, Nigel R. ;
Thommes, Pia .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) :1930-1933
[6]   Catalytic asymmetric [3+2] cycloaddition of azomethine ylides. Development of a versatile stepwise, three-component reaction for diversity-oriented synthesis [J].
Chen, C ;
Li, XD ;
Schreiber, SL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (34) :10174-10175
[7]   Treatment of chronic hepatitis C with PEGylated interferon and ribavirin. [J].
Cornberg M. ;
Wedemeyer H. ;
Manns M.P. .
Current Gastroenterology Reports, 2002, 4 (1) :23-30
[8]   An efficient, scalable synthesis of the HIV reverse transcriptase inhibitor Ziagen® (1592U89) [J].
Daluge, SM ;
Martin, MT ;
Sickles, BR ;
Livingston, DA .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2000, 19 (1-2) :297-327
[9]   Side effects of therapy of hepatitis C and their management [J].
Fried, MW .
HEPATOLOGY, 2002, 36 (05) :S237-S244
[10]  
Gothelf AS, 2002, ANGEW CHEM INT EDIT, V41, P4236, DOI 10.1002/1521-3773(20021115)41:22<4236::AID-ANIE4236>3.0.CO